WASHINGTON, D.C. — President Donald Trump returned to the White House promising that his second administration would put American workers, manufacturing, and industrial power at the center of the nation’s economic policy. Trump argued that decades of globalization had allowed factories, supply chains, and industrial jobs to move overseas while American communities suffered the economic consequences. His administration has sought to reverse that trend through tariffs, tax policy, deregulation, trade negotiations, and pressure on corporations to produce more goods in the United States. A growing number of major corporate investment announcements now give Trump examples he can point to as evidence that companies are expanding or planning new production inside the country.

One of the newest examples came on August 10, 2026, when Bristol Myers Squibb announced plans for a massive new manufacturing operation in Houston, Texas. The pharmaceutical company intends to invest approximately $2.3 billion in a state-of-the-art, approximately 600,000-square-foot facility at Generation Park. The project is expected to create nearly 500 permanent skilled jobs and roughly 2,000 construction and related jobs between 2027 and 2030. The facility is being designed to manufacture small-molecule drugs, biologics, and antibody-drug conjugates, with additional space available for future expansion.

The Houston facility is part of Bristol Myers Squibb’s broader commitment to invest $40 billion over five years in American research, development, technology, and manufacturing. Pharmaceutical manufacturing has become particularly important to the national discussion about reshoring because the COVID-19 pandemic exposed weaknesses created by dependence on foreign supply chains for medicines, pharmaceutical ingredients, and medical products. Expanding domestic production can create skilled employment while increasing America’s capacity to manufacture critical medicines at home.

Houston could receive economic benefits extending beyond the workers directly employed by Bristol Myers Squibb. Modern pharmaceutical plants require engineers, scientists, technicians, quality-control specialists, manufacturing employees, maintenance personnel, information-technology workers, and regulatory professionals. Construction also creates work for electricians, plumbers, welders, equipment installers, contractors, and other skilled trades. Large manufacturing facilities additionally purchase transportation, logistics, energy, supplies, and local services, allowing their economic impact to spread into surrounding communities. Texas is participating in the project as well, with Gov. Greg Abbott announcing a $4.89 million Texas Enterprise Fund grant for Bristol Myers Squibb.

Semiconductor manufacturing provides another major example. Micron Technology has announced plans for approximately $200 billion in American investment, including expanded semiconductor manufacturing and research. Its plans include another fabrication facility in Boise, Idaho, and modernization of its operation in Manassas, Virginia. The administration has also highlighted plans to bring advanced DRAM production previously performed in Taiwan to the United States. The White House says Micron’s broader investment could support approximately 90,000 direct and indirect jobs over time. Semiconductors are essential to automobiles, computers, smartphones, medical equipment, communications systems, defense technology, and artificial intelligence, making increased domestic chip production an economic and national-security priority.

Apple has announced approximately $600 billion in U.S. investment over four years involving manufacturing, suppliers, technology, and workforce development. Its American Manufacturing Program is intended to encourage more suppliers to manufacture components inside the United States, while the administration says the broader investment will support approximately 20,000 new jobs. Apple has not announced that every iPhone will be assembled domestically, but increasing American production of important components could reduce some of the company’s longstanding dependence on Asian manufacturing and strengthen its U.S. supplier network.

NVIDIA has announced plans associated with as much as $500 billion in American AI infrastructure and manufacturing over four years, with next-generation chip production underway in Arizona. Artificial intelligence requires far more than computer software: its expansion depends on semiconductors, servers, networking equipment, data centers, electrical infrastructure, cooling systems, construction, and enormous amounts of energy. Increasing the domestic share of that infrastructure could create an American industrial network extending well beyond the technology companies themselves.

Pharmaceutical companies are making some of the largest commitments. Johnson & Johnson has announced approximately $55 billion over four years for American manufacturing, research, and technology, including approximately $2 billion in manufacturing capacity at the FUJIFILM site in Holly Springs, North Carolina. AstraZeneca has announced approximately $50 billion in American manufacturing and research investment, Roche approximately $50 billion in U.S. manufacturing and research plans, and GSK approximately $30 billion in U.S. research, development, and manufacturing investment. Eli Lilly has also announced tens of billions of dollars intended to expand its American manufacturing capacity.

Louisiana stands to benefit from heavy manufacturing. Hyundai has announced an American investment program that includes a roughly $5.8 billion steel manufacturing plant in Louisiana, expected to create nearly 1,500 jobs. Steel has been central to Trump’s manufacturing argument because automobiles, buildings, bridges, ships, pipelines, factories, and military equipment depend upon it. The administration maintains that excessive dependence on foreign countries for essential industrial materials creates economic and national-security vulnerabilities.

The Midwest is receiving additional investment as well. Ford has announced approximately $5 billion across Kentucky and Michigan involving production of a new midsize truck and advanced batteries. Michigan is particularly important politically because Trump has repeatedly pointed to the decline of traditional manufacturing there as evidence of the consequences of globalization. New automotive and battery production gives his administration an opportunity to argue that the next generation of manufacturing can remain in traditional American industrial states rather than automatically migrating overseas or to Mexico.

Other announced investments extend the manufacturing footprint further. Pratt Industries has announced approximately $5 billion intended to create thousands of manufacturing jobs across Ohio, Michigan, Pennsylvania, and Arizona. Merck has expanded pharmaceutical production in North Carolina and plans a biologics manufacturing facility in Delaware expected to create hundreds of jobs. AbbVie has announced billions in long-term American manufacturing investment, while Carrier, Kraft Heinz, and Anheuser-Busch have announced additional investments in American production operations.

Trump has attempted to accelerate reshoring through tariffs and the threat of tariffs, using access to the enormous American consumer market as economic leverage. The administration’s argument is that companies producing overseas may face higher costs when importing goods into the United States, giving them an additional reason to locate manufacturing domestically. Supporters believe that approach can reverse incentives that encouraged production to leave the country. Critics argue that tariffs can also increase costs for American manufacturers dependent upon imported materials and components and can contribute to higher consumer prices.

The employment picture requires an important qualification. Manufacturing employment has not yet increased on the same scale as the enormous corporate investment announcements because major industrial projects can take years to complete. Land must be acquired, permits obtained, facilities constructed, equipment installed, production systems tested, and employees hired before a factory reaches full operation. Bristol Myers Squibb’s Houston project illustrates that timetable: the investment decision has been announced, but much of the construction and employment activity remains ahead.

Corporate commitments should therefore be distinguished from money already spent and jobs already created. Multibillion-dollar announcements frequently cover several years, and projects can be modified as economic conditions change. The more concrete evidence of reshoring comes when companies identify actual locations and facilities, such as the Bristol Myers Squibb campus in Houston, Micron’s semiconductor expansion in Boise, Hyundai’s steel plant in Louisiana, and pharmaceutical manufacturing projects in North Carolina.

Trump can nevertheless point to these projects as evidence that his promise to make the United States a more attractive location for manufacturing is taking visible form. Pharmaceuticals, semiconductors, steel, automobiles, batteries, artificial intelligence infrastructure, and other industries are attracting major announced investments across numerous states. The long-term measure of success will be whether those facilities are completed, their promised jobs materialize, manufacturing employment and wages increase, and the resulting industrial capacity remains in the United States.

Donate to support independent, free-thinking journalism—your donation helps us continue reporting the news with courage, independence, and a commitment to giving readers the facts they need to think for themselves.

____

By T. Williams, Staff Reporter contributed to this report.

(Copyrighted 2026) Bee News Daily All rights reserved.